Effects of Exercise on Sleep Quality in Patients With Obstructive Sleep Apnea Syndrome

NCT ID: NCT06006520

Last Updated: 2024-07-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-09-01

Study Completion Date

2023-12-05

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

the investigators aim in this study is to investigate the effects of aerobic and oropharyngeal exercises on sleep quality in patients with Obstructive Sleep Apnea Syndrome (OSAS).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The study will be conducted in a randomized controlled manner. Participants will be divided into groups of 3 equal numbers using the simple randomization method. The control group will not be given exercise. The first intervention group will be given 10-15 minutes of oropharyngeal exercises. In addition to oropharyngeal exercises, the second intervention group will be given 50 minutes of moderate-intensity aerobic exercise at least 3 days a week. Both intervention groups will apply the given exercise program for 8 weeks. All participants will be evaluated 3 times in total, at the beginning of the treatment, at the 4th week and at the 8th week. Epworth Sleepiness Scale, Pittsburgh Sleep Quality Questionnaire, Fatigue Severity Scale, Berlin Questionnaire, 6-minute walk test, Modified Medical Research Council (MMRC) Dyspnea Scale, Functional Results of Sleep Scale (FOSQ) tests will be applied to the participants. Pre- and post-intervention data were statistically analyzed and compared.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Osa Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

oropharyngeal exercises and aerobic exercises
Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

control group

No exercises will be given.

Group Type ACTIVE_COMPARATOR

control

Intervention Type OTHER

No exercises will be given.

oropharyngeal

oropharyngeal exercises will be given.

Group Type EXPERIMENTAL

oro-granary exercises.

Intervention Type OTHER

soft palate exercises language exercises facial exercises stomatognathic functions swallowing and chewing exercises

aerobic

In addition to oropharyngeal exercises, 50 minutes of moderate-intensity aerobic exercise will be given at least 3 days a week.

Group Type EXPERIMENTAL

oro-granary exercises.

Intervention Type OTHER

soft palate exercises language exercises facial exercises stomatognathic functions swallowing and chewing exercises

aerobic exercises

Intervention Type OTHER

We can think of aerobic exercise as a low-intensity long-term activity using large muscle groups (between 60-80% of maximal heart rate). For example; It includes activities such as walking, cycling, jogging, aerobic dancing, swimming.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

control

No exercises will be given.

Intervention Type OTHER

oro-granary exercises.

soft palate exercises language exercises facial exercises stomatognathic functions swallowing and chewing exercises

Intervention Type OTHER

aerobic exercises

We can think of aerobic exercise as a low-intensity long-term activity using large muscle groups (between 60-80% of maximal heart rate). For example; It includes activities such as walking, cycling, jogging, aerobic dancing, swimming.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* People who want to participate in the study voluntarily
* People who do not regularly engage in physical activity
* Persons diagnosed with OSAS in the neurology outpatient clinic
* People between the ages of 18-57
* Apnea Hypopnea Index 15-30

Exclusion Criteria

* Chronic obstructive pulmonary disease, presence of lung disease that may cause respiratory failure
* -Severe cardiac disease, congestive heart failure, detection of ejection fraction in echocardiography, uncontrollable cardiac ischemia
* History of previous cerebrovascular disease
* Neuromuscular disease
* Presence of periodic leg movements
* Serious medical illness or planned surgical intervention
* Psychiatric illness, substance abuse
Minimum Eligible Age

18 Years

Maximum Eligible Age

57 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Uskudar University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Dr. Öğr. Üyesi Ömer Şevgin

Asst. Prof. Dr.

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Eda ARSLAN

Role: STUDY_CHAIR

Uskudar University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Bolu

Bolu, , Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

References

Explore related publications, articles, or registry entries linked to this study.

Lee JJ, Sundar KM. Evaluation and Management of Adults with Obstructive Sleep Apnea Syndrome. Lung. 2021 Apr;199(2):87-101. doi: 10.1007/s00408-021-00426-w. Epub 2021 Mar 13.

Reference Type BACKGROUND
PMID: 33713177 (View on PubMed)

Chwiesko-Minarowska S, Minarowski L, Kuryliszyn-Moskal A, Chwiesko J, Chyczewska E. Rehabilitation of patients with obstructive sleep apnea syndrome. Int J Rehabil Res. 2013 Dec;36(4):291-7. doi: 10.1097/MRR.0b013e3283643d5f.

Reference Type BACKGROUND
PMID: 23873222 (View on PubMed)

Mohammadi H, Aarabi A, Rezaei M, Khazaie H, Brand S. Sleep Spindle Characteristics in Obstructive Sleep Apnea Syndrome (OSAS). Front Neurol. 2021 Feb 25;12:598632. doi: 10.3389/fneur.2021.598632. eCollection 2021.

Reference Type BACKGROUND
PMID: 33716919 (View on PubMed)

Xanthopoulos MS, Berkowitz RI, Tapia IE. Effects of obesity therapies on sleep disorders. Metabolism. 2018 Jul;84:109-117. doi: 10.1016/j.metabol.2018.01.022. Epub 2018 Feb 1.

Reference Type BACKGROUND
PMID: 29409812 (View on PubMed)

Guimaraes KC, Drager LF, Genta PR, Marcondes BF, Lorenzi-Filho G. Effects of oropharyngeal exercises on patients with moderate obstructive sleep apnea syndrome. Am J Respir Crit Care Med. 2009 May 15;179(10):962-6. doi: 10.1164/rccm.200806-981OC. Epub 2009 Feb 20.

Reference Type BACKGROUND
PMID: 19234106 (View on PubMed)

Arslan E, Sevgin O. The effects of Aerobic and oropharyngeal exercises on sleep quality of patients with obstructive sleep Apnoea syndrome: a randomized controlled study. Sleep Breath. 2024 Dec;28(6):2729-2736. doi: 10.1007/s11325-024-03157-3. Epub 2024 Sep 20.

Reference Type DERIVED
PMID: 39302514 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Uskudar60

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Physical Status of OSA Patients
NCT05051514 COMPLETED